Are you a new member? Sign up now
Login area
| Sign up
close
XALKORI - 250mg - 60
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01ED01 | B | Crizotinib - 250mg | 9727/388 | 169618/1 | XALKORI | 250mg | 60 | Capsule | Oral | Droguerie Fattal S.A.L. | Pfizer Manufacturing Deutschland GmbH | Germany | L.L | 2.44 | E2 | pfizer Canada ULC | Canada | 2/5/2024 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01ED01 | B | Crizotinib - 250mg | 9727 | 169618/1 | XALKORI | 250mg | 60 | Capsule | Oral | Droguerie Fattal S.A.L. | Pfizer Manufacturing Deutschland GmbH | Germany | 347,644,061 L.L | 2.44 | E2 | pfizer Canada ULC | Canada | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024